BioCentury | Jan 7, 2020
Financial News

Jan. 7 Financial Quick Takes: Deep Genomics raises $40M; plus Arcutis, Kintor file for IPOs, TwinStrand and RootPath

...company spun out of the University of Washington. RootPath raises series A for cancer immunotherapies RootPath Inc....
BioCentury | Aug 31, 2018
Financial News

Sequoia China leads seed round for next-gen T cell therapy play

...Sciences Yinqing Li; and Lead Scientist Ely Porter. RootPath Inc., Cambridge, Mass. Jennie Walters Baidu Ventures Nest.Bio Ventures Sequoia China Volcanics Venture RootPath Inc....
BioCentury | Aug 30, 2018
Financial News

Sequoia China leads seed round for next-gen T cell therapy play

RootPath Inc. (Cambridge, Mass.) raised $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated. Co-founder and CEO Xi Chen told BioCentury the...
Items per page:
1 - 3 of 3
BioCentury | Jan 7, 2020
Financial News

Jan. 7 Financial Quick Takes: Deep Genomics raises $40M; plus Arcutis, Kintor file for IPOs, TwinStrand and RootPath

...company spun out of the University of Washington. RootPath raises series A for cancer immunotherapies RootPath Inc....
BioCentury | Aug 31, 2018
Financial News

Sequoia China leads seed round for next-gen T cell therapy play

...Sciences Yinqing Li; and Lead Scientist Ely Porter. RootPath Inc., Cambridge, Mass. Jennie Walters Baidu Ventures Nest.Bio Ventures Sequoia China Volcanics Venture RootPath Inc....
BioCentury | Aug 30, 2018
Financial News

Sequoia China leads seed round for next-gen T cell therapy play

RootPath Inc. (Cambridge, Mass.) raised $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated. Co-founder and CEO Xi Chen told BioCentury the...
Items per page:
1 - 3 of 3